type here...

CATEGORIES

Healthcare

LATEST

1234...77Page 3 of 77

TRENDING

EDITORS CHOICE

Clinical Trials As a Care Option – the Time is Now

Irfan Khan MD -
Creating more effective, safer medicines starts with empowering new communities to join in on clinical research

The Power of Words

Gil Bashe, Medika Life Editor -
Harnessing Communications Across Disciplines to Heal Our Environment. The power of words must be translated into meaningful actions

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life -
SPRAVATO® (esketamine) CIII nasal spray, taken with an oral antidepressant, to treat depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior.

HT World Correspondent and Medika Editor Gil Bashe Talks with the Medika50 Influencer Who Put Everything On the Line for Patients

Gil Bashe, Medika Life Editor -
HT World talks to the healthcare influencer who put everything on the line for patient advocacy on her mission to deliver change on many fronts.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories